Llwytho...
In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
BACKGROUND: Troglitazone (TGZ) is a peroxisome proliferator-activated receptor gamma (PPARγ) agonist that has been investigated as a potential chemopreventive and chemotherapeutic agent. However, the antitumor efficacy and mechanisms of TGZ in pancreatic cancer have not been extensively investigated...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Exp Clin Cancer Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496133/ https://ncbi.nlm.nih.gov/pubmed/28673319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0557-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|